| It is now the age to define the appropriate follow-up of primary breast cancer patients |
| CL Loprinzi |
|
JCO May 1 1994: 881–883.
[PDF]
|
 |
| Ki-1/CD30+ (anaplastic) large-cell lymphoma: maturation of a clinicopathologic entity with prospects of effective therapy |
| ME Kadin |
|
JCO May 1 1994: 884–887.
[PDF]
|
|
|
Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer |
| |
AJ Nixon, D Neuberg, DF Hayes, R Gelman, JL Connolly, S Schnitt, A Abner, A Recht, F Vicini, and JR Harris |
| |
JCO May 1 1994: 888–894.
[Abstract]
[PDF]
|
|
|
Clinical features and treatment outcome for children with CD30+ large- cell non-Hodgkin's lymphoma |
| |
JT Sandlund, CH Pui, VM Santana, H Mahmoud, WM Roberts, S Morris, S Raimondi, R Ribeiro, WM Crist, and JS Lin |
| |
JCO May 1 1994: 895–898.
[Abstract]
[PDF]
|
|
|
Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies |
| |
A Reiter, M Schrappe, M Tiemann, R Parwaresch, M Zimmermann, E Yakisan, R Dopfer, P Bucsky, G Mann, and H Gadner |
| |
JCO May 1 1994: 899–908.
[Abstract]
[PDF]
|
|
|
11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia |
| |
CH Pui, FG Behm, JR Downing, ML Hancock, SA Shurtleff, RC Ribeiro, DR Head, HH Mahmoud, JT Sandlund, and WL Furman |
| |
JCO May 1 1994: 909–915.
[Abstract]
[PDF]
|
|
|
Late effects of intensive treatment for acute myeloid leukemia and myelodysplasia in childhood |
| |
RJ Liesner, AD Leiper, IM Hann, and JM Chessells |
| |
JCO May 1 1994: 916–924.
[Abstract]
[PDF]
|
|
|
Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma |
| |
JF McIntyre, B Smith-Sorensen, SH Friend, J Kassell, AL Borresen, YX Yan, C Russo, J Sato, N Barbier, and J Miser |
| |
JCO May 1 1994: 925–930.
[Abstract]
[PDF]
|
|
|
Etoposide and carboplatin: a highly effective combination in relapsed or refractory Wilms' tumor--a phase II study by the French Society of Pediatric Oncology |
| |
F Pein, MF Tournade, JM Zucker, M Brunat-Mentigny, A Deville, P Boutard, F Dusol, JC Gentet, E Legall, and F Mechinaud |
| |
JCO May 1 1994: 931–936.
[Abstract]
[PDF]
|
|
|
Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia |
| |
JS Lee, SM Lippman, SE Benner, JJ Lee, JY Ro, JM Lukeman, RC Morice, EJ Peters, AC Pang, and HA Fritsche, Jr |
| |
JCO May 1 1994: 937–945.
[Abstract]
[PDF]
|
|
|
Intensive induction chemotherapy and radiation for organ preservation in patients with advanced resectable head and neck carcinoma |
| |
SG Urba, AA Forastiere, GT Wolf, RM Esclamado, PW McLaughlin, and AF Thornton |
| |
JCO May 1 1994: 946–953.
[Abstract]
[PDF]
|
|
|
Evaluation and treatment of patients receiving radiation for cancer of the rectum or sigmoid colon in the United States: results of the 1988- 1989 Patterns of Care Study process survey |
| |
L Coia, M Wizenberg, A Hanlon, L Gunderson, D Haller, J Hoffman, R Kline, M Mohiuddin, A Russell, and J Tepper |
| |
JCO May 1 1994: 954–959.
[Abstract]
[PDF]
|
|
|
Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer. Advanced Colorectal Cancer Meta-Analysis Project |
| |
|
| |
JCO May 1 1994: 960–969.
[Abstract]
[PDF]
|
|
|
Adjuvant intraperitoneal cisplatin chemotherapy does not improve long- term survival after surgery for advanced gastric cancer |
| |
T Sautner, F Hofbauer, D Depisch, R Schiessel, and R Jakesz |
| |
JCO May 1 1994: 970–974.
[Abstract]
[PDF]
|
|
|
Neoadjuvant chemotherapy and partial cystectomy for invasive bladder cancer |
| |
HW Herr and HI Scher |
| |
JCO May 1 1994: 975–980.
[Abstract]
[PDF]
|
|
|
Surgical treatment of primary lung cancer in patients less than 40 years of age |
| |
T Shimono, T Hayashi, M Kimura, I Yada, S Namikawa, H Yuasa, and M Kusagawa |
| |
JCO May 1 1994: 981–985.
[Abstract]
[PDF]
|
|
|
Clinical activity of chronic oral etoposide in previously treated metastatic breast cancer |
| |
M Martin, A Lluch, A Casado, P Santabarbara, E Adrover, JJ Valverde, JA Lopez- Martin, A Rodriguez-Lescure, P Azagra, and J Garcia-Conde |
| |
JCO May 1 1994: 986–991.
[Abstract]
[PDF]
|
|
|
Tamoxifen and bone metabolism in postmenopausal low-risk breast cancer patients: a randomized study |
| |
B Kristensen, B Ejlertsen, P Dalgaard, L Larsen, SN Holmegaard, I Transbol, and HT Mouridsen |
| |
JCO May 1 1994: 992–997.
[Abstract]
[PDF]
|
|
|
Cardiac toxicity of bone marrow transplantation: predictive value of cardiologic evaluation before transplant |
| |
B Hertenstein, M Stefanic, T Schmeiser, M Scholz, V Goller, M Clausen, D Bunjes, M Wiesneth, J Novotny, and M Kochs |
| |
JCO May 1 1994: 998–1004.
[Abstract]
[PDF]
|
|
|
Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support |
| |
C Gilbert, B Meisenberg, J Vredenburgh, M Ross, A Hussein, J Perfect, and WP Peters |
| |
JCO May 1 1994: 1005–1011.
[Abstract]
[PDF]
|
|
|
Reinfusion and serial measurements of carboplatin-mobilized peripheral- blood progenitor cells in patients receiving multiple cycles of high- dose chemotherapy |
| |
TC Shea, JR Mason, M Breslin, E Bissent, M Mullen, and R Taetle |
| |
JCO May 1 1994: 1012–1020.
[Abstract]
[PDF]
|
|
|
Detection of tumor cells in purged bone marrow and peripheral-blood mononuclear cells by polymerase chain reaction amplification of bcl-2 translocations |
| |
RS Negrin and J Pesando |
| |
JCO May 1 1994: 1021–1027.
[Abstract]
[PDF]
|
|
|
Effects of topical tretinoin on dysplastic nevi |
| |
AC Halpern, LM Schuchter, DE Elder, D Guerry, 4th, R Elenitsas, B Trock, and I Matozzo |
| |
JCO May 1 1994: 1028–1035.
[Abstract]
[PDF]
|
|
|
Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside |
| |
PO Livingston, GY Wong, S Adluri, Y Tao, M Padavan, R Parente, C Hanlon, MJ Calves, F Helling, and G Ritter |
| |
JCO May 1 1994: 1036–1044.
[Abstract]
[PDF]
|
|
|
Dose-ranging evaluation of the serotonin antagonist dolasetron mesylate in patients receiving high-dose cisplatin |
| |
MG Kris, SM Grunberg, RJ Gralla, L Baltzer, SA Zaretsky, D Lifsey, LB Tyson, L Schmidt, and WF Hahne |
| |
JCO May 1 1994: 1045–1049.
[Abstract]
[PDF]
|
|
|
Effect of schedule and maintenance on the antiemetic efficacy of ondansetron combined with dexamethasone in acute and delayed nausea and emesis in patients receiving moderately emetogenic chemotherapy: a phase III trial by the National Cancer Institute of Canada Clinical Trials Group |
| |
L Kaizer, D Warr, P Hoskins, J Latreille, W Lofters, J Yau, M Palmer, B Zee, M Levy, and J Pater |
| |
JCO May 1 1994: 1050–1057.
[Abstract]
[PDF]
|
|
|
Recombinant human erythropoietin treatment in cisplatin-associated anemia: a randomized, double-blind trial with placebo |
| |
S Cascinu, A Fedeli, E Del Ferro, S Luzi Fedeli, and G Catalano |
| |
JCO May 1 1994: 1058–1062.
[Abstract]
[PDF]
|
|
|
Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage |
| |
FE van Leeuwen, AM Chorus, AW van den Belt-Dusebout, A Hagenbeek, R Noyon, EH van Kerkhoff, HM Pinedo, and R Somers |
| |
JCO May 1 1994: 1063–1073.
[Abstract]
[PDF]
|
|
|
Significance of a partial or slow response to front-line chemotherapy in the management of intermediate-grade or high-grade non-Hodgkin's lymphoma: a literature review |
| |
R Haw, CA Sawka, E Franssen, and NL Berinstein |
| |
JCO May 1 1994: 1074–1084.
[Abstract]
[PDF]
|
|
|
Stereotactic radiosurgery: a review and comparison of methods |
| |
MH Phillips, KJ Stelzer, TW Griffin, MR Mayberg, and HR Winn |
| |
JCO May 1 1994: 1085–1099.
[Abstract]
[PDF]
|
|
| Is there a place for blood stem-cell transplantation for the younger adult patient with acute myelogenous leukemia? BGMT Group |
| J Reiffers, AM Stoppa, M Attal, and M Michallet |
|
JCO May 1 1994: 1100–1102.
[PDF]
|
|
| Neurotoxicity as a possible manifestation of paclitaxel hypersensitivity reactions |
| DL McCauley, K Calzone, and M Wicha |
|
JCO May 1 1994: 1102a–1103.
[PDF]
|
|
| Predictors of response: new versus old? |
| B Vikram |
|
JCO May 1 1994: 1102b.
[PDF]
|
|
| Tricuspid endocarditis induced by implantable venous access |
| B Weidmann, T Hanseler, C Jimenez, and N Niederle |
|
JCO May 1 1994: 1103–1105.
[PDF]
|
|
